SCHEMBL14973272

SCHEMBL14973272

CCOC(=O)c1cnn(C)c1COc1cccc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
KDM4E B2RXH2 3/20 0.49
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CSNK1D P48730 1/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 2/20 0.45
RAB9A P51151 1/20 0.45
GAA P10253 3/20 0.45
PKM P14618 1/20 0.44
HPGD P15428 3/20 0.43
HSD17B10 Q99714 2/20 0.43
ALOX15 P16050 1/20 0.43
FOS P01100 1/20 0.42
JUN P05412 1/20 0.42
NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14973126 0.88 MAPT (0.57) ALDH1A1KDM4EMAPTSMN1; SMN2LMNA
SCHEMBL14973180 0.88 BRAF (0.47) KDM4EMAPTSMN1; SMN2TP53TSHR
SCHEMBL14973111 0.88 PAX8 (0.47) ALDH1A1KDM4EMAPTSMN1; SMN2CSNK1D
SCHEMBL14973188 0.87 TSHR (0.52) ALDH1A1KDM4EMAPTSMN1; SMN2TP53
SCHEMBL14973063 0.86 LMNA (0.52) ALDH1A1KDM4EMAPTSMN1; SMN2TP53
SCHEMBL14973299 0.82 JMJD6 (0.45) ALDH1A1KDM4EMAPTSMN1; SMN2LMNA
SCHEMBL14973274 0.80 SMN1; SMN2 (0.52) ALDH1A1KDM4EMAPTSMN1; SMN2MAPK1
SCHEMBL14973085 0.80 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTSMN1; SMN2TSHR
SCHEMBL14972952 0.77 MAPT (0.52) ALDH1A1KDM4EMAPTSMN1; SMN2L3MBTL1
SCHEMBL14973295 0.77 NPC1 (0.52) ALDH1A1KDM4EMAPTSMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2604602-A1 HETEROARYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-19 EP disclosed
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A ALDH1A1 2263/4885KDM4E 4251/4885MAPT 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.